CVS HEALTH Corp (CVS) earnings date, results and what the price requires
NYSE · SEC CIK 0000064803 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $106.10B | $2.98B | $2.31 | Filing |
| Mar 31, 2026 | May 6, 2026 | $100.43B | $2.94B | $2.30 | Filing |
| Dec 31, 2025 | Feb 10, 2026 | $105.69B | $2.94B | $2.31 | Filing |
| Sep 30, 2025 | Oct 29, 2025 | $102.87B | $-3.98B | $-3.13 | Filing |
| Jun 30, 2025 | Jul 31, 2025 | $98.92B | $1.02B | $0.80 | Filing |
| Mar 31, 2025 | May 1, 2025 | $94.59B | $1.78B | $1.41 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | $97.71B | $1.64B | $1.30 | Filing |
| Sep 30, 2024 | Oct 18, 2024 | $95.43B | $87.0M | $0.07 | Filing |
What would CVS HEALTH Corp have to report for its valuation to change?
At $92.58, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 15.9% a year, to $7.91. On that path the next quarter needs diluted EPS near $-3.63, against $-3.13 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 15.9% | 15.9% |
| EPS needed in final year | $7.91 | $7.91 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CVS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.